Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study

Background: Unresectable cholangiocarcinoma prognosis can be extremely variable due to different symptoms and sites of disease involvement at diagnosis and unpredictable chemotherapy response rates. Most patients will usually receive 1st line palliative chemotherapy with platinum compounds and Gemci...

Descripción completa

Detalles Bibliográficos
Autores principales: Liguori, Carolina, Copparoni, Cecilia, Felicetti, Cristiano, Pecci, Federica, Lupi, Alessio, Pinterpe, Giada, Berardi, Rossana, Giampieri, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857714/
https://www.ncbi.nlm.nih.gov/pubmed/36661728
http://dx.doi.org/10.3390/curroncol30010079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857714/
https://www.ncbi.nlm.nih.gov/pubmed/36661728
http://dx.doi.org/10.3390/curroncol30010079

Ejemplares similares